We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
What are the regulatory challenges and opportunities that exist in media production for cell and gene therapies? In this webinar, Marlin Frechette, Corporate Read more...
What are the regulations and requirements that raw material suppliers need to understand to develop commercially viable advanced therapies? In a discussion led by Read more...
FUJIFILM Irvine Scientific discusses FAQ around custom media development
Custom cell culture media can be critical to optimizing bioproduction, and enable Read more...
Erik Vaessen, Head of Sales and Marketing – Bioproduction, and Cell & Gene Therapy at FUJIFILM Irvine Scientific, recently spoke with Phacilitate—a market Read more...
FUJIFILM Irvine Scientific CEO Yutaka Yamaguchi interviewed by Bioinformant
Yutaka Yamaguchi, CEO of FUJIFILM Irvine Scientific, was recently invited to sit down Read more...
Recently Marlin Frechette, FUJIFILM Irvine Scientific's Sr. Director of Quality Systems/Regulatory Affairs/Compliance Officer & ISO Management Representative, Read more...
Robert Newman, PhD, Chief Scientific Officer, FUJIFILM Irvine Scientific recently participated in a panel discussion among cell culture media experts about current Read more...
Hope is what keeps dreams alive and what sustains patients battling infertility through their arduous IVF journey to see their dream of a family realized. On August Read more...
We recently sat down with Catherine Nguyen, a rising scientist at Irvine Scientific who oversees our Media Survey Panel program, to discuss the key differences Read more...
Cell therapy scientists searching for a potent tool to fight cancer have zeroed in on the potential of natural killer (NK) cells because they have the innate Read more...